Elanco Animal Health Incorporated
ELANNYSEHealthcareDrug Manufacturers - Specialty & Generic

About Elanco Animal Health Incorporated

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Stock Details

ExchangeNYSE (NYSE)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone877 352 6261
Address
2500 Innovation Way Greenfield, Indiana 46140 United States

Corporate Identifiers

CIK0001739104
CUSIP28414H103
ISINUS28414H1032
EIN82-5497352
SIC2834

Leadership Team & Key Executives

Jeffrey N. Simmons
President, Chief Executive Officer and Director
Dr. Ramiro Martin Cabral
Executive Vice President and President of Elanco International
Dr. Ellen de Brabander Ph.D.
Executive Vice President of Research, Development and Regulatory Affairs
Timothy J. Bettington
Executive Vice President of Corporate Strategy and Market Development
Robert M. VanHimbergen
Executive Vice President and Chief Financial Officer
James M. Meer
Senior Vice President and Chief Accounting Officer
Chris Keeley
Senior Vice President and Chief Information Officer
David S. Kinard
Executive Vice President of Human Resources, Corporate Communications and Administration
Tiffany Ann Kanaga
Vice President of Investor Relations and ESG
Shiv O'Neill
Executive Vice President, General Counsel and Corporate Secretary